A Post-Marketing Safety Study to Evaluate the Occurrence of Aseptic Meningitis Syndrome (AMS) in an Adult Population (>= 18 Years) Treated with Doses of >= 1g/kg Intragam® 10 NF First published 28/02/2017 Last updated 07/09/2017 EU PAS number:EUPAS17881 Study Ongoing